Status:
COMPLETED
National Tunisian Registry of Valvulopathies (NATURE-VALVE)
Lead Sponsor:
Dacima Consulting
Collaborating Sponsors:
Tunisian Society of Cardiology and Cardiovascular Surgery
Conditions:
Valvular Heart Disease
Valvular Stenosis
Eligibility:
All Genders
18+ years
Brief Summary
The National Tunisian Registry of Valvulopathies is an observational, prospective and multicenter study aiming to assess the epidemiological, clinical and therapeutic profile of valve disease in tunis...
Eligibility Criteria
Inclusion
- Patients originated from Tunisia
- Signed informed consent
- Patients with at least one of the following conditions :
- moderate to severe native mitral and / or aortic and / or tricuspid native valve disease
- and / or a history of a previous percutaneous or surgical valve intervention
- and / or a history of infectious endocarditis
Exclusion
- Congenital valve diseases not including bicuspid aortic valve
- Isolated pulmonary valvulopathies
Key Trial Info
Start Date :
July 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2022
Estimated Enrollment :
3637 Patients enrolled
Trial Details
Trial ID
NCT04509479
Start Date
July 6 2020
End Date
July 30 2022
Last Update
August 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Tunisian Society of Cardiology and CardioVascular Surgery
Tunis, Tunisia, 1053